In virtually every country in the world, governments, social security fund managers and health insurers are struggling with ever increasing drug bills. This note explains cost drivers, provides insights into private sector strategies and discusses how to strike the balance between cost containment and access to innovative medicines. Policy makers in many countries are struggling to cope with increasing costs for pharmaceuticals. Pharmaceutical expenses...
انظر المزيد
تفاصيل
-
2005/8/01
-
مذكرة موجزة
-
35560
-
1
-
1
-
2006/3/27
-
Disclosed
-
Pharmaceuticals: cost containment, pricing, reimbursement
-
research and development need